Microbot Medical Inc
MBOT
Get informed when a big investor buys or sells
+ FollowMarket Cap$92.51M
Close$
$0.07
96.6% downside
Current Fair Value
96.6% downsideOvervalued by 96.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $92.51 Million |
|---|---|
| Enterprise Value | $89.75 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.29 |
| Beta | 1.06 |
| Outstanding Shares | 67,158,044 |
Return
| Return on Equity | -8.14% |
|---|---|
| Return on Assets | -7.73% |
| Return on Invested Capital | -15.65% |
Valuation & Multiples
| P/E Ratio | -9.59 |
|---|---|
| PEG | -1.83 |
| Price to Sales | - |
| Price to Book Ratio | 1.97 |
| Enterprise Value to Revenue | 854.75 |
| Enterprise Value to EBIT | -7.68 |
| Enterprise Value to Net Income | -15 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
$450,000
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
$675,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.5901▼ 138.17% |
|---|---|
| Total Calls | 162,631▲ 35.08% |
| Total Puts | 258,600▼ 27.72% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 31.09%▲ 7.41% |
|---|---|
| Total Invested | $34.31M▲ 50.63% |
| Investors Holding | 86▲ 11.00% |
ESG Score
No data
About Microbot Medical Inc
15 employees
CEO: Harel Gadot Microbot Medical Inc. is a pre-clinical medical device company that specializes in transformational micro-robotic technologies, focused primarily on both natural and artificial lumens within the human body. Microbot's current proprietary...